Search alternatives:
point decrease » point increase (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
15061
-
15062
Simultaneously inhibition <i>Nlu-miR-34</i> and <i>NlInR2</i> in SW strain induced the decrease of SW BPHs.
Published 2019“…<p>(A) Antagomir-34 (with two different quantities) and ds<i>NlInR2</i> (0.84 ng) were injected into the third instar SW strain nymphs, showed that injection of antagomir-34 decreased the ratio of SW type BPH (Chi-square test, 40ng: χ<sup>2</sup> = 5.8, df = 1, <i>p</i> = 0.003; 60ng: χ<sup>2</sup> = 7.9, df = 1, <i>p</i> = 0.042). …”
-
15063
-
15064
-
15065
Change in average relative abundance of significantly different ASVs within distinct phyla classifications at all three time points for the three different treatments.
Published 2020“…<p><b>A.</b> For the control treatment, the change in average relative abundance of significantly different bacteria taxa in their relative phyla classifications generally decreased throughout consecutive time points. …”
-
15066
Copper-Based Complexes with Adamantane Ring-Conjugated <i>bis</i>(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma
Published 2024“…The new ligand L<sup>2Ad</sup>, obtained by conjugating the bifunctional species bis(3,5-dimethylpyrazol-1-yl)-acetate and the drug amantadine, was used as a chelator for the synthesis of new Cu complexes <b>1</b>–<b>5</b>. …”
-
15067
Table_5_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx
Published 2022“…The cohorts were monitored from the 12th day after the first vaccine dose up to 1 month after the third vaccine dose for a total of eight time points and about 1 year of surveillance (T1 = 12 days after the first dose; T2 = 10 days after the second dose; T3 = 1 month after the second dose; T4 = 3 months after the second dose; T5 = 4 months after the second dose; T6 = 5 months after the second dose; T7 = 7 months after the second dose; T8 = 1 month after the third dose for Group 1; T8* = 9 months after the second dose for Group 2; T9 = 1 month after the third dose for Group 2). …”
-
15068
-
15069
-
15070
-
15071
-
15072
-
15073
Adduct Formation between Alkali Metal Ions and Anionic LV<sup>V</sup>O<sub>2</sub><sup>-</sup> (L<sup>2-</sup> = Tridentate ONS Ligands) Species: Syntheses, Structural Investigati...
Published 2003“…The putative product is a mixed-oxidation (μ-oxo)divanadium(IV/V) species as revealed from EPR, electronic spectroscopy, dynamic <sup>1</sup>H NMR, and redox studies.…”
-
15074
-
15075
Average tumor values of DCE-MRI derived parameters at different time points before and after PDT, for treated and non-treated animals.
Published 2016“…Directly after PDT, the average tumor K<sup>trans</sup> decreased and v<sub>e</sub> increased significantly compared to baseline based on repeated measures (both: <i>p</i> < 0.0001), and also compared to untreated animals at the same time point (<i>p</i> < 0.0001 and <i>p</i> = 0.038, respectively).…”
-
15076
-
15077
-
15078
-
15079
HIS-24 associates with promoters of <i>mab-5</i> and <i>egl-5</i> genes.
Published 2012“…<p>(A) <i>mab-5</i> and <i>egl-5</i> genes are tightly clustered on chromosome III. …”
-
15080
Baseline characteristics of participants<sup>a</sup>.
Published 2024“…The weighted prevalence of obesity in all ages significantly increased from 30.8% (29.1%-32.5%) in 2014 to 34.5% (32.9%-36.2%) in 2017 and 37.3% (35.5%-39.1%) in 2021 (<i>p</i> for trend < 0.004). …”